177Lu and 227Th Labeled 3,4,3-(LI-1,2-HOPO): characterization, optimized synthesis, biological distribution and dosimetry

Objectives: Interest in targeted radionuclide therapy has greatly increased namely due to the FDA approval of radiotherapeutic drugs such as Lutathera The identification of chelators that can bind diag- nostic and therapeutic radionuclides would allow facile development of agents tailored for person...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Nuclear medicine and biology 2022-12, Vol.114-115, p.S25-S26
Hauptverfasser:	Sanders, Vanessa, Phipps, Michael, Demoin, Dustin, Pratt, Edwin, Bhupathiraju, N.V.S. Dinesh, Ponnala, Shashikanth, Ferdous, Jannatul, Schlyer, David, Carter, Lukas, Lewis, Jason, Deri, Melissa, Cutler, Cathy, Francesconi, Lynn
Format:	Artikel
Sprache:	eng
Schlagworte:	RADIOLOGY AND NUCLEAR MEDICINE
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!